Literature DB >> 11399997

Lactic acid levels in children perinatally treated with antiretroviral agents to prevent HIV transmission.

C Giaquinto1, A De Romeo, V Giacomet, O Rampon, E Ruga, A Burlina, A De Rossi, M Sturkenboom, R D'Elia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11399997     DOI： 10.1097/00002030-200105250-00023

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  11 in total

Review 1.  Treating HIV during pregnancy: an update on safety issues.

Authors:  D Heather Watts
Journal:  Drug Saf       Date:  2006       Impact factor: 5.606

2.  Point-of-care capillary blood lactate measurements in human immunodeficiency virus-uninfected children with in utero exposure to human immunodeficiency virus and antiretroviral medications.

Authors:  Marilyn J Crain; Paige L Williams; Ray Griner; Katherine Tassiopoulos; Jennifer S Read; Lynne M Mofenson; Kenneth C Rich
Journal:  Pediatr Infect Dis J       Date:  2011-12       Impact factor: 2.129

3.  Effects of in utero antiretroviral exposure on mitochondrial DNA levels, mitochondrial function and oxidative stress.

Authors:  A C Ross; T Leong; A Avery; M Castillo-Duran; H Bonilla; D Lebrecht; U A Walker; N Storer; D Labbato; A Khaitan; I Tomanova-Soltys; G A McComsey
Journal:  HIV Med       Date:  2011-11-21       Impact factor: 3.180

4.  Serum lactate levels in infants exposed peripartum to antiretroviral agents to prevent mother-to-child transmission of HIV: Agence Nationale de Recherches Sur le SIDA et les Hépatites Virales 1209 study, Abidjan, Ivory Coast.

Authors:  Didier Koumavi Ekouevi; Ramata Touré; Renaud Becquet; Ida Viho; Charlotte Sakarovitch; François Rouet; Besigin Towne-Gold; Patricia Fassinou; Valériane Leroy; Stéphane Blanche; François Dabis
Journal:  Pediatrics       Date:  2006-09-01       Impact factor: 7.124

5.  Cancer Among Children With Perinatal Exposure to HIV and Antiretroviral Medications--New Jersey, 1995-2010.

Authors:  Wade Ivy; Steve R Nesheim; Sindy M Paul; Abdel R Ibrahim; Miranda Chan; Xiaoling Niu; Margaret A Lampe
Journal:  J Acquir Immune Defic Syndr       Date:  2015-09-01       Impact factor: 3.731

Review 6.  HIV-exposed uninfected children: a growing population with a vulnerable immune system?

Authors:  L Afran; M Garcia Knight; E Nduati; B C Urban; R S Heyderman; S L Rowland-Jones
Journal:  Clin Exp Immunol       Date:  2014-04       Impact factor: 4.330

7.  Antiretroviral drugs for preventing mother-to-child transmission of HIV in sub-Saharan Africa: balancing efficacy and infant toxicity.

Authors:  Andrea L Ciaranello; George R Seage; Kenneth A Freedberg; Milton C Weinstein; Shahin Lockman; Rochelle P Walensky
Journal:  AIDS       Date:  2008-11-12       Impact factor: 4.177

8.  Evaluation and treatment of the human immunodeficiency virus-1-exposed infant.

Authors: 
Journal:  Paediatr Child Health       Date:  2004-07       Impact factor: 2.253

Review 9.  Mitochondrial disorders among infants exposed to HIV and antiretroviral therapy.

Authors:  Michele Jonsson Funk; Suzanne E Belinson; Jeanne M Pimenta; Megan Morsheimer; David C Gibbons
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606

Review 10.  Safety of agents used to prevent mother-to-child transmission of HIV: is there any cause for concern?

Authors:  Claire Thorne; Marie-Louise Newell
Journal:  Drug Saf       Date:  2007       Impact factor: 5.606
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.